Table 5.
Antimicrobial resistance profile of Escherichia coli from patients with BSI to commonly used antibiotics.
| Escherichia coli | 2015 | 2016 | 2017 | 2018 | 2019 | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Antibiotic | n. Assays | R % | n. Assays | R % | n. Assays | R % | n. Assays | R % | n. Assays | R % |
| Amoxicillin/A. Clav. | 70 | 50.0 | 66 | 56.1 | 103 | 39.8 | 84 | 51.2 | 110 | 68.2 |
| Cefotaxime | 73 | 53.5 | 74 | 54.1 | 110 | 52.7 | 87 | 57.5 | 83 | 54.2 |
| Ciprofloxacin | 73 | 61.6 | 74 | 68.9 | 110 | 66.3 | 87 | 67.8 | 87 | 71.3 |
| Ertapenem | 73 | 1.4 | 74 | 0 | 110 | 0 | 87 | 2.3 | 87 | 2.3 |
| Fosfomycin | 70 | 0 | 66 | 0 | 103 | 4.9 | 84 | 0 | 70 | 0 |
| Gentamicin | 73 | 34.2 | 74 | 40.5 | 110 | 27.3 | 87 | 27.6 | 87 | 31.0 |
| Imipenem | 73 | 0 | 74 | 0 | 110 | 0 | 74 | 0 | 23 | 0 |
| Meropenem | 73 | 0 | 74 | 0 | 110 | 0 | 87 | 2.3 | 87 | 2.2 |
| Piperacillin/tazobactam | 72 | 15.3 | 74 | 10.8 | 110 | 18.2 | 86 | 12.8 | 85 | 14.1 |
| Tigecycline | 72 | 0 | 73 | 0 | 109 | 0 | 85 | 0 | 81 | 1.2 |
| Trimethoprim/Sulf. | 73 | 41.1 | 74 | 43.2 | 110 | 45.5 | 87 | 52.9 | 87 | 55.2 |